Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started.
نویسنده
چکیده
A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.
منابع مشابه
It’s Time to Finally Kill the Zombies; Comment on “Universal Pharmacare in Canada”
The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to “fill in the gaps,” ie, cover those who currently are uninsured or underinsured, that private drug plans are superior to public ones because t...
متن کاملCorruption in Health Systems: The Conversation Has Started, Now Time to Continue it; Comment on “We Need to Talk About Corruption in Health Systems”
Holistic and multi-disciplinary responses should be prioritized given the depth and breadth through which corruption in the healthcare sector can cover. Here, taking the Peruvian context as an example, we will reflect on the issue of corruption in health systems, including corruption with roots within and outside the health sector, and ongoing efforts to combat it. Our ...
متن کاملFailures of medicare part d delivery and recommendations for improvement.
mularies and benefits to include a full range of treatment options then in use by prescription drug plans. Mandates imposed by the MMA included a requirement that Part D was to provide the most clinically appropriate medications at the lowest achievable cost for all Part D beneficiaries. The MMA also required CMS to acknowledge the specific needs of individuals who were already stabilized with ...
متن کاملCMS Considering Pharmacy Counter Discounts for Part D Drugs in Future Other Pharmacy Changes Are Likely for 2019.
CMS considering pharmacy counter discounts for Part D drugs in the future.
متن کاملHHS Proposes Formulary Changes For Marketplace Health Plans: P&T Committees Would Take On a More Visible Role.
The federal government is proposing changes to the pharmacy benefit of marketplace plans in 2016 that (among other things) would increase the power of P&T committees, revise minimum "drug count" standards, and tighten conflict-of-interest rules.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 43 2 شماره
صفحات -
تاریخ انتشار 2018